These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31402613)

  • 21. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
    JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis for intracerebral hemorrhage during ongoing oral anticoagulant treatment.
    Apostolaki-Hansson T; Ullberg T; Norrving B; Petersson J
    Acta Neurol Scand; 2019 May; 139(5):415-421. PubMed ID: 30657164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register.
    Tallroth M; Udumyan R; Büki A; von Euler M
    J Am Heart Assoc; 2024 May; 13(10):e034716. PubMed ID: 38726922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portuguese Observational Study of Ischaemic Stroke in Patients Medicated with Non-Vitamin K Antagonist Oral Anticoagulants.
    Beato-Coelho J; Marto JP; Alves JN; Marques-Matos C; Calado S; Araújo J; Cunha L; Pinho J; Azevedo E; Viana-Baptista M; Sargento-Freitas J
    Eur Neurol; 2018; 79(1-2):108-112. PubMed ID: 29421803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebral hemorrhage outcomes in patients using direct oral anticoagulants versus vitamin K antagonists: a meta-analysis.
    Ahmed A; Ahmed R; Ali SS; Patel U; Shahid I; Zafar M; Sharma A; Ashraf A; Jani V
    Clin Neurol Neurosurg; 2020 Nov; 198():106146. PubMed ID: 32823187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
    Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
    J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Madžar D; Reindl C; Bobinger T; Müller T; Hoelter P; Lücking H; Engelhorn T; Huttner HB
    Int J Stroke; 2021 Jan; 16(1):83-92. PubMed ID: 31870241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study.
    Hohnloser SH; Basic E; Nabauer M
    Thromb Haemost; 2019 Jun; 119(6):882-893. PubMed ID: 30900220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
    Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta-analysis.
    Tsivgoulis G; Zand R; Katsanos AH; Turc G; Nolte CH; Jung S; Cordonnier C; Fiebach JB; Scheitz JF; Klinger-Gratz PP; Oppenheim C; Goyal N; Safouris A; Mattle HP; Alexandrov AW; Schellinger PD; Alexandrov AV
    JAMA Neurol; 2016 Jun; 73(6):675-83. PubMed ID: 27088650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage.
    Miller MM; Lowe J; Khan M; Azeem MU; Muehlschlegel S; Jun-O'Connell AH; Goddeau RP; Moonis M; Gritters D; Silver B; Henninger N
    Neurocrit Care; 2019 Aug; 31(1):56-65. PubMed ID: 30690686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helsinki experience on nonvitamin K oral anticoagulants for treating cervical artery dissection.
    Mustanoja S; Metso TM; Putaala J; Heikkinen N; Haapaniemi E; Salonen O; Tatlisumak T
    Brain Behav; 2015 Aug; 5(8):e00349. PubMed ID: 26356074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage.
    Sembill JA; Kuramatsu JB; Gerner ST; Sprügel MI; Roeder SS; Madžar D; Hagen M; Hoelter P; Lücking H; Dörfler A; Schwab S; Huttner HB
    Ann Clin Transl Neurol; 2020 Mar; 7(3):363-374. PubMed ID: 32133793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis.
    Katsanos AH; Schellinger PD; Köhrmann M; Filippatou A; Gurol ME; Caso V; Paciaroni M; Perren F; Alexandrov AV; Tsivgoulis G
    Eur J Neurol; 2018 Oct; 25(10):1299-1302. PubMed ID: 29953696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants.
    Purrucker JC; Rizos T; Haas K; Wolf M; Khan S; Heuschmann PU; Veltkamp R;
    Neurocrit Care; 2017 Oct; 27(2):208-213. PubMed ID: 28477151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.